These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 26597668

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies.
    Bell EJ, Agarwal SK, Cushman M, Heckbert SR, Lutsey PL, Folsom AR.
    Am J Hypertens; 2016 May; 29(5):634-40. PubMed ID: 26306405
    [Abstract] [Full Text] [Related]

  • 4. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.
    Zakai NA, McClure LA, Judd SE, Safford MM, Folsom AR, Lutsey PL, Cushman M.
    Circulation; 2014 Apr 08; 129(14):1502-9. PubMed ID: 24508826
    [Abstract] [Full Text] [Related]

  • 5. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
    Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH.
    Ann Intern Med; 1997 Apr 01; 126(7):528-31. PubMed ID: 9092318
    [Abstract] [Full Text] [Related]

  • 6. Reasons for Differences in the Incidence of Venous Thromboembolism in Black Versus White Americans.
    Folsom AR, Basu S, Hong CP, Heckbert SR, Lutsey PL, Rosamond WD, Cushman M, Atherosclerosis Risk in Communities (ARIC) Study.
    Am J Med; 2019 Aug 01; 132(8):970-976. PubMed ID: 30953632
    [Abstract] [Full Text] [Related]

  • 7. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
    Pabinger I, Ay C, Dunkler D, Thaler J, Reitter EM, Marosi C, Zielinski C, Mannhalter C.
    J Thromb Haemost; 2015 Jan 01; 13(1):17-22. PubMed ID: 25381723
    [Abstract] [Full Text] [Related]

  • 8. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
    Perez Botero J, Ormsby WD, Ashrani AA, McBane RD, Wysokinski WE, Patnaik MM, Lewis BR, Grill DE, Pruthi RK, Heit JA.
    Eur J Intern Med; 2016 May 01; 30():77-81. PubMed ID: 26970916
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals.
    Hyacinth HI, Franceschini N, Seals SR, Irvin MR, Chaudhary N, Naik RP, Alonso A, Carty CL, Burke GL, Zakai NA, Winkler CA, David VA, Kopp JB, Judd SE, Adams RJ, Gee BE, Longstreth WT, Egede L, Lackland DT, Greenberg CS, Taylor H, Manson JE, Key NS, Derebail VK, Kshirsagar AV, Folsom AR, Konety SH, Howard V, Allison M, Wilson JG, Correa A, Zhi D, Arnett DK, Howard G, Reiner AP, Cushman M, Safford MM.
    JAMA Netw Open; 2021 Jan 04; 4(1):e2030435. PubMed ID: 33399855
    [Abstract] [Full Text] [Related]

  • 12. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
    Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG.
    CMAJ; 2013 Mar 19; 185(5):E229-37. PubMed ID: 23382263
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.
    Roetker NS, Armasu SM, Pankow JS, Lutsey PL, Tang W, Rosenberg MA, Palmer TM, MacLehose RF, Heckbert SR, Cushman M, de Andrade M, Folsom AR.
    J Thromb Haemost; 2017 Jul 19; 15(7):1334-1343. PubMed ID: 28445597
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association Between Sickle Cell Trait With Selected Chronic Medical Conditions in U.S. Service Members.
    Niebuhr DW, Chen L, Shao S, Goldsmith J, Byrne C, Singer DE.
    Mil Med; 2018 Nov 01; 183(11-12):e735-e740. PubMed ID: 29889287
    [Abstract] [Full Text] [Related]

  • 18. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG.
    Arterioscler Thromb Vasc Biol; 2016 May 01; 36(5):1030-6. PubMed ID: 26988593
    [Abstract] [Full Text] [Related]

  • 19. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I, Papadakis M, Brenner B, Fidalgo Á, Rivas A, Wells PS, Gavín O, Adarraga MD, Moustafa F, Monreal M, Registro Informatizado de Enfermedad TromboEmbólica Investigators.
    Am J Med; 2017 Apr 01; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.